ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10161	Companies
208736	Keywords
138859	Articles
110648	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 10 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website

Shareholders Biotechnology Abivax General Meeting Preparatory Documents
BRIEF

published on 04/30/2024 at 18:05, 1 year 11 months ago

ABIVAX reports the number of shares and voting rights as of March 31, 2024

Share Capital Voting Rights Financial Markets Authority Abivax Regulatory Information
BRIEF

published on 04/05/2024 at 22:05, 1 year 11 months ago

Abivax Announces Submission of Financial Reports to French and U.S. Regulatory Agencies

Abivax Financial Reports Chronic Inflammatory Diseases Regulatory Agencies Webcast Announcement
PRESS RELEASE

published on 04/05/2024 at 22:00, 1 year 11 months ago

Abivax publishes financial reports with the French and U.S. securities regulatory agencies
Abivax publishes 2023 financial reports with French and U.S. securities regulators, including annual report and governance information

Abivax Financial Reports Regulatory Agencies French Securities U.S. Securities
BRIEF

published on 04/02/2024 at 08:35, 2 years ago

Abivax Reports 2023 Financial Results and Operational Update

Financial Results Abivax Obefazimod Ulcerative Colitis Nasdaq IPO
PRESS RELEASE

published on 04/02/2024 at 08:30, 2 years ago

Abivax reports 2023 financial results and operational update
Abivax reports 2023 financial results & operational update. Raised EUR 500M, aims to finance operations till Q4 2025. Webcast on April 8, 2024

Financial Results Fundraising Abivax Webcast Operational Update
BRIEF

published on 03/27/2024 at 18:05, 2 years ago

ABIVAX publishes its number of shares and voting rights as of February 29, 2024

Euronext Paris Share Capital Voting Rights Abivax Regulation
BRIEF

published on 02/23/2024 at 18:00, 2 years 1 month ago

ABIVAX announces an update on its share capital and voting rights

Share Capital Voting Rights Biotechnology Abivax Financial Transparency
PRESS RELEASE

published on 02/13/2024 at 08:30, 2 years 1 month ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)
Abivax to present four abstracts on obefazimod for ulcerative colitis at 19th ECCO Congress, including a sponsored symposium on emerging treatment mechanisms. Event details available on ECCO website

Abivax Obefazimod Ulcerative Colitis ECCO Congress Scientific Symposium
PRESS RELEASE

published on 02/07/2024 at 08:30, 2 years 1 month ago

Abivax appoints Ana Sharma as Vice President, Global Head of Quality
Abivax appoints Ana Sharma as Vice President, Global Head of Quality. Ana Sharma brings over 20 years of experience in the biopharmaceutical industry and has a strong track record in quality and GxP compliance

Abivax Ana Sharma Biopharmaceutical Industry Quality Compliance GxP

Accesswire

Published on 04/02/2026 at 22:00, 2 days 21 hours ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 3 days 1 hour ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 3 days 4 hours ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 3 days 5 hours ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 3 days 5 hours ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/04/2026 at 10:07, 1 day 9 hours ago

Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 1 day 17 hours ago

Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 2 days 1 hour ago

IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 2 days 1 hour ago

Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 17:05, 2 days 2 hours ago

At WMF a new edition of AI Global Summit, an international reference point on Artificial Intelligence

Les Echos

Published on 04/03/2026 at 18:46, 2 days ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 17:45, 2 days 1 hour ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 04/03/2026 at 17:45, 2 days 1 hour ago

Information concerning the total number of voting rights and shares 2026 03 31
Published on 04/03/2026 at 17:45, 2 days 1 hour ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 04/03/2026 at 17:45, 2 days 1 hour ago

March 2026

View all LES ECHOS COMFI WIRE